Cherokee Insurance’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.76M Hold
30,600
0.68% 48
2026
Q1
$1.86M Hold
30,600
0.7% 42
2025
Q4
$1.65M Hold
30,600
0.67% 44
2025
Q3
$1.38M Hold
30,600
0.59% 47
2025
Q2
$1.42M Hold
30,600
0.62% 45
2025
Q1
$1.87M Hold
30,600
0.82% 37
2024
Q4
$1.73M Buy
+30,600
New +$1.71M 0.78% 38

Other funds holding BMY

Cherokee Insurance's BMY Position: Q2 2026 in Review

Cherokee Insurance held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 30,600 shares worth $1.76M. The position accounts for 0.68% of the portfolio, ranked #48.

Cherokee Insurance first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.87M in Q1 2025. 2,524 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Cherokee Insurance held 30,600 shares of Bristol-Myers Squibb worth $1.76M as of Q2 2026.
  • Cherokee Insurance left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up 0.68% of Cherokee Insurance's portfolio in Q2 2026, its #48 holding.
  • Cherokee Insurance first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
  • Cherokee Insurance's Bristol-Myers Squibb position peaked at $1.87M in Q1 2025.
  • 2,524 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Cherokee Insurance's 13F filing for Q2 2026, filed 3 Aug 2026.